Hedge Fund and Insider Trading News: Bill Ackman, Paul Singer, Julian Robertson, Pelham Capital, Tyler Technologies, Inc. (TYL), Biohaven Pharmaceutical Holding Co Ltd.(BHVN), and More

Hedge Funder Ackman Explains His Stockholdings and Exits (The Street)
Many investors pay close attention to the moves of hedge-fund heavyweight Bill Ackman, given his successful investing track record. The chief executive of Pershing Square Capital Management discussed his stock positions (and former positions) within the Pershing Square Holdings fund in a letter to shareholders. Here are his comments on several of them.

Julian Robertson, Hedge-Fund Guru to ‘Tiger Cubs,’ Dies at 90 (Bloomberg)
Julian Robertson, the billionaire Tiger Management founder who became one of his generation’s most successful hedge-fund managers and a mentor to a wave of investors known as Tiger Cubs, has died. He was 90. He died at his home in Manhattan from cardiac complications, according to Fraser Seitel, a longtime spokesman for Robertson.

Paul Singer Notices Company That Keeps Screwing Up Keeps Screwing Up (Deal Breaker)
It’s hard to screw up in the drug distribution game. You’ve only got two competitors and you don’t have to spend heavily on developing those drugs. All you have to do is get them from point A to point B and watch the money roll in. That’s why AmerisourceBergen shares are up nearly 80% over the past two years, and why McKesson Corp. shares have more than doubled. It’s also why Paul Singer wants to know why Cardinal Health shares… haven’t.

leungchopan/Shutterstock.com

Hedge Funds Dampen Aalto University Endowment’s Losses (Hedge Nordic)
Stockholm (HedgeNordic) – Aalto University’s endowment fund incurred a loss of 5.1 percent during the first half of 2022 amid wider market turmoil, as hedge fund investments helped dampen losses. The endowment fund’s “alternative risk” building block, a portfolio of hedge fund investments accounting for 20 percent of the €1.29 billion endowment portfolio, returned 11.1 percent in the first six months of 2022. “Our hedge funds had a terrific H1 across most strategies,” Lauri Ström, Portfolio Manager at Aalto University Endowment, writes on LinkedIn.

Ampersand Capital Hits $1.2bn Hard Cap Target for Its Latest Fund, Ampersand 2022 (Opalesque)
American alternative investment firm Ampersand Capital Partners announced the closing of the firm’s latest fund with $1.2 billion in limited partner commitments. Ampersand 2022 (AMP-22), which is Ampersand’s eleventh primary fund since 1992, was significantly oversubscribed and held a single close less than three months after launch, said the private equity firm specializing in growth equity investments in the life sciences and healthcare sectors.